Global Cancer Anorexia-Cachexia Syndrome Drug Market Growth 2024-2031

Report ID: 1503206 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Cancer Anorexia-Cachexia Syndrome Drug by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Cancer Anorexia-Cachexia Syndrome Drug by Country/Region, 2017, 2022 & 2028
    2.2 Cancer Anorexia-Cachexia Syndrome Drug Segment by Type
        2.2.1 NEO-1940
        2.2.2 C-1889
        2.2.3 DLN-101
        2.2.4 Foxo1-nRNA
        2.2.5 AVGN-7
        2.2.6 Others
    2.3 Cancer Anorexia-Cachexia Syndrome Drug Sales by Type
        2.3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)
        2.3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sale Price by Type (2017-2022)
    2.4 Cancer Anorexia-Cachexia Syndrome Drug Segment by Application
        2.4.1 Hospital
        2.4.2 Clinic
        2.4.3 Others
    2.5 Cancer Anorexia-Cachexia Syndrome Drug Sales by Application
        2.5.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sale Market Share by Application (2017-2022)
        2.5.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sale Price by Application (2017-2022)
3 Global Cancer Anorexia-Cachexia Syndrome Drug by Company
    3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Breakdown Data by Company
        3.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Sales by Company (2020-2022)
        3.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Company (2020-2022)
    3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Revenue by Company (2020-2022)
        3.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Company (2020-2022)
        3.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Company (2020-2022)
    3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sale Price by Company
    3.4 Key Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Product Location Distribution
        3.4.2 Players Cancer Anorexia-Cachexia Syndrome Drug Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cancer Anorexia-Cachexia Syndrome Drug by Geographic Region
    4.1 World Historic Cancer Anorexia-Cachexia Syndrome Drug Market Size by Geographic Region (2017-2022)
        4.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Revenue by Geographic Region
    4.2 World Historic Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country/Region (2017-2022)
        4.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Revenue by Country/Region
    4.3 Americas Cancer Anorexia-Cachexia Syndrome Drug Sales Growth
    4.4 APAC Cancer Anorexia-Cachexia Syndrome Drug Sales Growth
    4.5 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Growth
    4.6 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Growth
5 Americas
    5.1 Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
        5.1.1 Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022)
        5.1.2 Americas Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022)
    5.2 Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Type
    5.3 Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Region
        6.1.1 APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2017-2022)
        6.1.2 APAC Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2017-2022)
    6.2 APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Type
    6.3 APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Cancer Anorexia-Cachexia Syndrome Drug by Country
        7.1.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022)
        7.1.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022)
    7.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Type
    7.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug by Country
        8.1.1 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022)
    8.2 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Type
    8.3 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Cancer Anorexia-Cachexia Syndrome Drug
    10.3 Manufacturing Process Analysis of Cancer Anorexia-Cachexia Syndrome Drug
    10.4 Industry Chain Structure of Cancer Anorexia-Cachexia Syndrome Drug
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Cancer Anorexia-Cachexia Syndrome Drug Distributors
    11.3 Cancer Anorexia-Cachexia Syndrome Drug Customer
12 World Forecast Review for Cancer Anorexia-Cachexia Syndrome Drug by Geographic Region
    12.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Region
        12.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Forecast by Region (2023-2028)
        12.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Cancer Anorexia-Cachexia Syndrome Drug Forecast by Type
    12.7 Global Cancer Anorexia-Cachexia Syndrome Drug Forecast by Application
13 Key Players Analysis
    13.1 Acacia Pharma Ltd
        13.1.1 Acacia Pharma Ltd Company Information
        13.1.2 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Offered
        13.1.3 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Acacia Pharma Ltd Main Business Overview
        13.1.5 Acacia Pharma Ltd Latest Developments
    13.2 Aeterna Zentaris Inc
        13.2.1 Aeterna Zentaris Inc Company Information
        13.2.2 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered
        13.2.3 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Aeterna Zentaris Inc Main Business Overview
        13.2.5 Aeterna Zentaris Inc Latest Developments
    13.3 Aphios Corp
        13.3.1 Aphios Corp Company Information
        13.3.2 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Offered
        13.3.3 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Aphios Corp Main Business Overview
        13.3.5 Aphios Corp Latest Developments
    13.4 Incyte Corp
        13.4.1 Incyte Corp Company Information
        13.4.2 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Offered
        13.4.3 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Incyte Corp Main Business Overview
        13.4.5 Incyte Corp Latest Developments
    13.5 Lakewood-Amedex Inc
        13.5.1 Lakewood-Amedex Inc Company Information
        13.5.2 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered
        13.5.3 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Lakewood-Amedex Inc Main Business Overview
        13.5.5 Lakewood-Amedex Inc Latest Developments
    13.6 Novartis AG
        13.6.1 Novartis AG Company Information
        13.6.2 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Offered
        13.6.3 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Novartis AG Main Business Overview
        13.6.5 Novartis AG Latest Developments
    13.7 Obexia AG
        13.7.1 Obexia AG Company Information
        13.7.2 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Offered
        13.7.3 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Obexia AG Main Business Overview
        13.7.5 Obexia AG Latest Developments
    13.8 PsiOxus Therapeutics Ltd
        13.8.1 PsiOxus Therapeutics Ltd Company Information
        13.8.2 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Offered
        13.8.3 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 PsiOxus Therapeutics Ltd Main Business Overview
        13.8.5 PsiOxus Therapeutics Ltd Latest Developments
    13.9 RaQualia Pharma Inc
        13.9.1 RaQualia Pharma Inc Company Information
        13.9.2 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered
        13.9.3 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 RaQualia Pharma Inc Main Business Overview
        13.9.5 RaQualia Pharma Inc Latest Developments
    13.10 Viking Therapeutics Inc
        13.10.1 Viking Therapeutics Inc Company Information
        13.10.2 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered
        13.10.3 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Viking Therapeutics Inc Main Business Overview
        13.10.5 Viking Therapeutics Inc Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Cancer Anorexia-Cachexia Syndrome Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Cancer Anorexia-Cachexia Syndrome Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of NEO-1940
    Table 4. Major Players of C-1889
    Table 5. Major Players of DLN-101
    Table 6. Major Players of Foxo1-nRNA
    Table 7. Major Players of AVGN-7
    Table 8. Major Players of Others
    Table 9. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
    Table 10. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)
    Table 11. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2017-2022) & ($ million)
    Table 12. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2017-2022)
    Table 13. Global Cancer Anorexia-Cachexia Syndrome Drug Sale Price by Type (2017-2022) & (USD/Pcs)
    Table 14. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
    Table 15. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)
    Table 16. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2017-2022)
    Table 17. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2017-2022)
    Table 18. Global Cancer Anorexia-Cachexia Syndrome Drug Sale Price by Application (2017-2022) & (USD/Pcs)
    Table 19. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Company (2020-2022) & (K Pcs)
    Table 20. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Company (2020-2022)
    Table 21. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Company (2020-2022) ($ Millions)
    Table 22. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Company (2020-2022)
    Table 23. Global Cancer Anorexia-Cachexia Syndrome Drug Sale Price by Company (2020-2022) & (USD/Pcs)
    Table 24. Key Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Producing Area Distribution and Sales Area
    Table 25. Players Cancer Anorexia-Cachexia Syndrome Drug Products Offered
    Table 26. Cancer Anorexia-Cachexia Syndrome Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 27. New Products and Potential Entrants
    Table 28. Mergers & Acquisitions, Expansion
    Table 29. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Geographic Region (2017-2022) & (K Pcs)
    Table 30. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Geographic Region (2017-2022)
    Table 31. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 32. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Geographic Region (2017-2022)
    Table 33. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Country/Region (2017-2022) & (K Pcs)
    Table 34. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country/Region (2017-2022)
    Table 35. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country/Region (2017-2022) & ($ millions)
    Table 36. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country/Region (2017-2022)
    Table 37. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
    Table 38. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2017-2022)
    Table 39. Americas Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 40. Americas Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2017-2022)
    Table 41. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
    Table 42. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)
    Table 43. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
    Table 44. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)
    Table 45. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2017-2022) & (K Pcs)
    Table 46. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2017-2022)
    Table 47. APAC Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2017-2022) & ($ Millions)
    Table 48. APAC Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2017-2022)
    Table 49. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
    Table 50. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)
    Table 51. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
    Table 52. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)
    Table 53. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
    Table 54. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2017-2022)
    Table 55. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 56. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2017-2022)
    Table 57. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
    Table 58. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)
    Table 59. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
    Table 60. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)
    Table 61. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
    Table 62. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2017-2022)
    Table 63. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 64. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2017-2022)
    Table 65. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
    Table 66. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)
    Table 67. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
    Table 68. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)
    Table 69. Key Market Drivers & Growth Opportunities of Cancer Anorexia-Cachexia Syndrome Drug
    Table 70. Key Market Challenges & Risks of Cancer Anorexia-Cachexia Syndrome Drug
    Table 71. Key Industry Trends of Cancer Anorexia-Cachexia Syndrome Drug
    Table 72. Cancer Anorexia-Cachexia Syndrome Drug Raw Material
    Table 73. Key Suppliers of Raw Materials
    Table 74. Cancer Anorexia-Cachexia Syndrome Drug Distributors List
    Table 75. Cancer Anorexia-Cachexia Syndrome Drug Customer List
    Table 76. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 77. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Forecast by Region
    Table 78. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 79. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 80. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 81. Americas Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 83. APAC Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 84. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 85. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 87. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 88. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 89. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Type (2023-2028)
    Table 90. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 91. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 92. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 93. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Application (2023-2028)
    Table 94. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 95. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 96. Acacia Pharma Ltd Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
    Table 97. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Offered
    Table 98. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 99. Acacia Pharma Ltd Main Business
    Table 100. Acacia Pharma Ltd Latest Developments
    Table 101. Aeterna Zentaris Inc Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
    Table 102. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered
    Table 103. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 104. Aeterna Zentaris Inc Main Business
    Table 105. Aeterna Zentaris Inc Latest Developments
    Table 106. Aphios Corp Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
    Table 107. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Offered
    Table 108. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 109. Aphios Corp Main Business
    Table 110. Aphios Corp Latest Developments
    Table 111. Incyte Corp Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
    Table 112. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Offered
    Table 113. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 114. Incyte Corp Main Business
    Table 115. Incyte Corp Latest Developments
    Table 116. Lakewood-Amedex Inc Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
    Table 117. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered
    Table 118. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 119. Lakewood-Amedex Inc Main Business
    Table 120. Lakewood-Amedex Inc Latest Developments
    Table 121. Novartis AG Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
    Table 122. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Offered
    Table 123. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 124. Novartis AG Main Business
    Table 125. Novartis AG Latest Developments
    Table 126. Obexia AG Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
    Table 127. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Offered
    Table 128. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 129. Obexia AG Main Business
    Table 130. Obexia AG Latest Developments
    Table 131. PsiOxus Therapeutics Ltd Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
    Table 132. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Offered
    Table 133. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 134. PsiOxus Therapeutics Ltd Main Business
    Table 135. PsiOxus Therapeutics Ltd Latest Developments
    Table 136. RaQualia Pharma Inc Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
    Table 137. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered
    Table 138. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 139. RaQualia Pharma Inc Main Business
    Table 140. RaQualia Pharma Inc Latest Developments
    Table 141. Viking Therapeutics Inc Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
    Table 142. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered
    Table 143. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 144. Viking Therapeutics Inc Main Business
    Table 145. Viking Therapeutics Inc Latest Developments
List of Figures
    Figure 1. Picture of Cancer Anorexia-Cachexia Syndrome Drug
    Figure 2. Cancer Anorexia-Cachexia Syndrome Drug Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate 2017-2028 (K Pcs)
    Figure 7. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of NEO-1940
    Figure 10. Product Picture of C-1889
    Figure 11. Product Picture of DLN-101
    Figure 12. Product Picture of Foxo1-nRNA
    Figure 13. Product Picture of AVGN-7
    Figure 14. Product Picture of Others
    Figure 15. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2021
    Figure 16. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2017-2022)
    Figure 17. Cancer Anorexia-Cachexia Syndrome Drug Consumed in Hospital
    Figure 18. Global Cancer Anorexia-Cachexia Syndrome Drug Market: Hospital (2017-2022) & (K Pcs)
    Figure 19. Cancer Anorexia-Cachexia Syndrome Drug Consumed in Clinic
    Figure 20. Global Cancer Anorexia-Cachexia Syndrome Drug Market: Clinic (2017-2022) & (K Pcs)
    Figure 21. Cancer Anorexia-Cachexia Syndrome Drug Consumed in Others
    Figure 22. Global Cancer Anorexia-Cachexia Syndrome Drug Market: Others (2017-2022) & (K Pcs)
    Figure 23. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)
    Figure 24. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application in 2021
    Figure 25. Cancer Anorexia-Cachexia Syndrome Drug Revenue Market by Company in 2021 ($ Million)
    Figure 26. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Company in 2021
    Figure 27. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Geographic Region (2017-2022)
    Figure 28. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Geographic Region in 2021
    Figure 29. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2017-2022)
    Figure 30. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country/Region in 2021
    Figure 31. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales 2017-2022 (K Pcs)
    Figure 32. Americas Cancer Anorexia-Cachexia Syndrome Drug Revenue 2017-2022 ($ Millions)
    Figure 33. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales 2017-2022 (K Pcs)
    Figure 34. APAC Cancer Anorexia-Cachexia Syndrome Drug Revenue 2017-2022 ($ Millions)
    Figure 35. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales 2017-2022 (K Pcs)
    Figure 36. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue 2017-2022 ($ Millions)
    Figure 37. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales 2017-2022 (K Pcs)
    Figure 38. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue 2017-2022 ($ Millions)
    Figure 39. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country in 2021
    Figure 40. Americas Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country in 2021
    Figure 41. United States Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Canada Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Mexico Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Brazil Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 45. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region in 2021
    Figure 46. APAC Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Regions in 2021
    Figure 47. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Japan Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 49. South Korea Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 51. India Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Australia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country in 2021
    Figure 54. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country in 2021
    Figure 55. Germany Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 56. France Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 57. UK Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Italy Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Russia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country in 2021
    Figure 61. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country in 2021
    Figure 62. Egypt Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 63. South Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Israel Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 65. Turkey Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 66. GCC Country Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 67. Manufacturing Cost Structure Analysis of Cancer Anorexia-Cachexia Syndrome Drug in 2021
    Figure 68. Manufacturing Process Analysis of Cancer Anorexia-Cachexia Syndrome Drug
    Figure 69. Industry Chain Structure of Cancer Anorexia-Cachexia Syndrome Drug
    Figure 70. Channels of Distribution
    Figure 71. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Cancer Anorexia-Cachexia Syndrome Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Cancer Anorexia-Cachexia Syndrome Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Cancer Anorexia-Cachexia Syndrome Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports